The attenuation of poliovirus neurovirulence.

PubWeight™: 1.42‹?› | Rank: Top 5%

🔗 View Article (PMID 2825586)

Published in Annu Rev Microbiol on January 01, 1987

Authors

J W Almond1

Author Affiliations

1: Department of Microbiology, University of Reading, England.

Articles citing this

Conservation of the secondary structure elements of the 5'-untranslated region of cardio- and aphthovirus RNAs. Nucleic Acids Res (1989) 3.81

Biologic importance of neuraminidase stalk length in influenza A virus. J Virol (1993) 3.51

Translation of poliovirus RNA: role of an essential cis-acting oligopyrimidine element within the 5' nontranslated region and involvement of a cellular 57-kilodalton protein. J Virol (1991) 2.86

Attenuation of influenza A virus by insertion of a foreign epitope into the neuraminidase. J Virol (1992) 2.37

A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J Virol (1996) 2.29

Identification of two determinants that attenuate vaccine-related type 2 poliovirus. J Virol (1991) 2.00

Role of alpha/beta interferon in Venezuelan equine encephalitis virus pathogenesis: effect of an attenuating mutation in the 5' untranslated region. J Virol (2001) 1.87

Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J Virol (1992) 1.80

The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region. J Virol (1995) 1.64

Restricted growth of attenuated poliovirus strains in cultured cells of a human neuroblastoma. J Virol (1989) 1.53

A single nucleotide change in the 5' noncoding region of Sindbis virus confers neurovirulence in rats. J Virol (1999) 1.11

Effects of the Sabin-like mutations in domain V of the internal ribosome entry segment on translational efficiency of the Coxsackievirus B3. Mol Genet Genomics (2006) 0.82

A single chimpanzee-human neutralizing monoclonal antibody provides post-exposure protection against type 1 and type 2 polioviruses. J Clin Virol (2015) 0.77

Creation of matrix protein gene variants of two serotypes of vesicular stomatitis virus as prime-boost vaccine vectors. J Virol (2015) 0.75